Beaucell launches stem-cell skin care
This article was originally published in The Rose Sheet
Executive Summary
Korea-based firm FCB-Pharmicell introduces Anti-Aging Regeneration Daily Program to "inspire vitality and clearness to your damaged and exhausted skin," at HBA Global Expo. Program includes a toner which "refines surface texture" and an emulsion "leaving the surface fully moist and elastic." Each contains 0.5% adult stem-cell extract. In addition, an anti-wrinkle eye cream contains yeast proteins and grain peptide to "provide elasticity and bright clearness," a cream with hexa-peptides for "flexibility" and an essence gel "for nourishment and moisture," all containing 7% adult stem-cell extract. Firm has studied anti-aging effects of stem cell media and currently has three products in IND-Phases 2 and 3 targeting acute ischemic stroke, acute myocardial infarction and spinal cord injury. Beaucell's five-product kit retails for $800 in spas
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.